
|Articles|May 15, 2006
Surgical strategy returns to the surface
San Francisco-Advanced surface treatment (AST) with the Epi-Kkeratome (Moria) is a significant advance in laser visioncorrection but necessitates special attention to pain relief andvisual recovery, said Henry "Rick" Milne III, MD, a refractivesurgeon in Columbia, SC, who has performed more than 300 cases withthis technique.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
3
Neurotrophic keratitis outcomes improve with early, stage-based care
4
Alcon raises offer in amended deal to acquire STAAR Surgical
5













































.png)


